Topics

FDA requests withdrawal of bacitracin for injection from market

08:42 EST 31 Jan 2020 | FDA

FDA requested that all current manufacturers of bacitracin for injection voluntarily withdraw their product from the market. FDA believes that the potential problems associated with bacitracin for injection are sufficiently serious to remove the drug from the market.

Original Article: FDA requests withdrawal of bacitracin for injection from market

NEXT ARTICLE

More From BioPortfolio on "FDA requests withdrawal of bacitracin for injection from market"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...